ATG7 and pachyonychia congenita: Emerging evidence suggests that ISG15, a protein involved in post-translational modifications, stabilizes ATG7 structure and function while augmenting autophagic flux to counteract gemcitabine (GEM) sensitivity in pancreatic cancer (PC) therapy—a factor associated with poor prognosis in PC (60).